Septerna is a biotechnology company focused on pioneering GPCR drug discovery through its proprietary Native Complex Platform™, aiming to develop oral small molecule therapies targeting GPCRs across various therapeutic areas
Septerna is a biotechnology company focused on pioneering GPCR drug discovery through its proprietary Native Complex Platform™, aiming to develop oral small molecule therapies targeting GPCRs across various therapeutic areas.
Septerna is a biotechnology company focused on pioneering GPCR drug discovery through its proprietary Native Complex Platform™, aiming to develop oral small molecule therapies targeting GPCRs across various therapeutic areas
Septerna is a biotechnology company focused on pioneering GPCR drug discovery through its proprietary Native Complex Platform™, aiming to develop oral small molecule therapies targeting GPCRs across various therapeutic areas.